These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 34650779)

  • 1. Accelerated blood clearance of targeted ultrasound contrast reduced molecular imaging signal intensity: Secreted Frizzled Related Protein-2 signal remained significantly higher than signal from either Vascular Endothelial Growth Factor Receptor-2 or alpha
    Tsuruta J; White R; Klauber-DeMore N; Dayton PA
    IEEE Int Ultrason Symp; 2019 Oct; 2019():407-410. PubMed ID: 34650779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma.
    Tsuruta JK; Schaub NP; Rojas JD; Streeter J; Klauber-DeMore N; Dayton P
    PLoS One; 2017; 12(3):e0174281. PubMed ID: 28333964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound molecular imaging of secreted frizzled related protein-2 expression in murine angiosarcoma.
    Tsuruta JK; Klauber-DeMore N; Streeter J; Samples J; Patterson C; Mumper RJ; Ketelsen D; Dayton P
    PLoS One; 2014; 9(1):e86642. PubMed ID: 24489757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies.
    Fix SM; Nyankima AG; McSweeney MD; Tsuruta JK; Lai SK; Dayton PA
    Ultrasound Med Biol; 2018 Jun; 44(6):1266-1280. PubMed ID: 29602540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
    Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
    Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
    Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
    Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of Microbubbles for Targeted Ultrasound Contrast Imaging: Practical Translation Considerations.
    Unnikrishnan S; Du Z; Diakova GB; Klibanov AL
    Langmuir; 2019 Aug; 35(31):10034-10041. PubMed ID: 30509068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model.
    Helbert A; Von Wronski M; Colevret D; Botteron C; Padilla F; Bettinger T; Tardy I; Hyvelin JM
    Invest Radiol; 2020 Oct; 55(10):657-665. PubMed ID: 32229739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin.
    Leguerney I; Scoazec JY; Gadot N; Robin N; Pénault-Llorca F; Victorin S; Lassau N
    Ultrasound Med Biol; 2015 Jan; 41(1):197-207. PubMed ID: 25308938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of ovarian tumor detection with αvβ3 integrin-targeted ultrasound molecular imaging agent in laying hens: a preclinical model of spontaneous ovarian cancer.
    Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Int J Gynecol Cancer; 2014 Jan; 24(1):19-28. PubMed ID: 24304684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Ultrasound Imaging.
    Baier J; Rix A; Kiessling F
    Recent Results Cancer Res; 2020; 216():509-531. PubMed ID: 32594397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound molecular imaging of vascular endothelial growth factor receptor 2 expression for endometrial receptivity evaluation.
    Liu H; Chen Y; Yan F; Han X; Wu J; Liu X; Zheng H
    Theranostics; 2015; 5(2):206-17. PubMed ID: 25553109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
    Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Ultrason Imaging; 2015 Jul; 37(3):224-37. PubMed ID: 25294846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.
    Palmowski M; Huppert J; Ladewig G; Hauff P; Reinhardt M; Mueller MM; Woenne EC; Jenne JW; Maurer M; Kauffmann GW; Semmler W; Kiessling F
    Mol Cancer Ther; 2008 Jan; 7(1):101-9. PubMed ID: 18202013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.
    Lee DJ; Lyshchik A; Huamani J; Hallahan DE; Fleischer AC
    J Ultrasound Med; 2008 Jun; 27(6):855-66. PubMed ID: 18499845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo targeted contrast enhanced micro-ultrasound to measure intratumor perfusion and vascular endothelial growth factor receptor 2 expression in a mouse orthotopic bladder cancer model.
    Chan ES; Patel AR; Larchian WA; Heston WD
    J Urol; 2011 Jun; 185(6):2359-65. PubMed ID: 21511281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies.
    Daeichin V; Kooiman K; Skachkov I; Bosch JG; Theelen TL; Steiger K; Needles A; Janssen BJ; Daemen MJ; van der Steen AF; de Jong N; Sluimer JC
    Ultrasound Med Biol; 2016 Sep; 42(9):2283-93. PubMed ID: 27302657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.